Clinical Medicine Insights-Endocrinology and Diabetes

Scope & Guideline

Transforming knowledge into practice for better health.

Introduction

Explore the comprehensive scope of Clinical Medicine Insights-Endocrinology and Diabetes through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Clinical Medicine Insights-Endocrinology and Diabetes in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1179-5514
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2009 to 2024
AbbreviationCLIN MED INSIGHTS-EN / Clin. Med. Insights-Endocrinol. Diabetes
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Clinical Medicine Insights-Endocrinology and Diabetes' focuses on the multifaceted aspects of endocrine disorders and diabetes, emphasizing clinical research, innovative therapies, and the integration of technology in treatment protocols. It aims to bridge the gap between clinical practice and research, providing a platform for the dissemination of knowledge that can enhance patient care and outcomes.
  1. Endocrine Disorders Research:
    The journal publishes studies related to various endocrine disorders, including thyroid diseases, adrenal dysfunctions, and metabolic syndromes, with an emphasis on understanding their pathophysiology and clinical implications.
  2. Diabetes Management and Treatment Innovations:
    A significant focus is placed on the latest advancements in diabetes management, including pharmacological interventions, lifestyle modifications, and technological innovations such as digital health tools.
  3. Clinical Trials and Meta-Analyses:
    The journal features systematic reviews and meta-analyses that synthesize evidence from clinical trials, providing insights into the efficacy and safety of treatments for endocrine and metabolic disorders.
  4. Socio-Cultural Aspects of Diabetes Care:
    Research that explores the impact of socio-cultural factors on diabetes management and health outcomes is highlighted, recognizing the importance of culturally sensitive approaches in patient care.
  5. Emerging Biomarkers and Diagnostic Tools:
    The publication emphasizes the identification and validation of new biomarkers for early diagnosis and monitoring of endocrine and metabolic conditions, leveraging advanced technologies such as LC-MS/MS.
The journal has recently seen an increase in publications addressing contemporary issues and innovative solutions in endocrinology and diabetes, reflecting the evolving landscape of research and clinical practice.
  1. Digital Health Interventions:
    There is a growing emphasis on the role of digital health technologies in diabetes prevention and management, highlighting the importance of telehealth, mobile apps, and wearable devices in improving patient outcomes.
  2. Mental Health and Diabetes:
    Recent publications have increasingly addressed the intersection of mental health and diabetes, recognizing the psychological impact of chronic disease management and the need for integrated care approaches.
  3. Diabetes and COVID-19 Research:
    The impact of COVID-19 on diabetes management and the risk of severe outcomes in diabetic patients has become a significant theme, reflecting the pandemic's influence on clinical practice and research priorities.
  4. Cultural Competence in Diabetes Care:
    Emerging studies focusing on culturally sensitive diabetes management strategies are on the rise, underscoring the importance of tailoring interventions to diverse patient populations.
  5. Innovative Biomarkers for Disease Monitoring:
    There is an increased focus on the discovery and validation of novel biomarkers for metabolic diseases, which may enhance early diagnosis and personalized treatment strategies.

Declining or Waning

While the journal continues to cover a broad spectrum of topics in endocrinology and diabetes, certain themes have shown a decline in frequency, reflecting shifts in research focus and emerging priorities in the field.
  1. Historical Perspectives on Diabetes:
    Papers that explore historical approaches and treatments for diabetes have become less prominent, as the focus shifts towards contemporary evidence-based practices and innovations.
  2. Traditional Pharmacological Approaches:
    There has been a noticeable decrease in studies centered on older, less effective diabetes medications, as newer therapies gain prominence and researchers focus more on novel agents and combination therapies.
  3. Single-Centric Studies:
    Research that is limited to single-center studies is waning, with a growing preference for multi-center trials that provide more generalizable results and broader insights into treatment efficacy.
  4. Generalized Epidemiological Studies:
    There is a diminishing focus on broad epidemiological studies without specific interventions or outcomes, as the journal increasingly emphasizes studies that link findings to clinical practice and patient management.
  5. Basic Science without Clinical Relevance:
    Basic science research that does not translate into clinical applications or implications for patient care is appearing less frequently, as the journal aims to prioritize studies with direct relevance to clinical practice.

Similar Journals

Journal of Endocrinology and Metabolism

Illuminating the path to breakthroughs in endocrinology and metabolism.
Publisher: ELMER PRESS INCISSN: 1923-2861Frequency: 4 issues/year

Journal of Endocrinology and Metabolism is a dynamic and essential publication in the field of endocrinology, diabetes, and metabolism, published by ELMER PRESS INC in Canada. With an ISSN of 1923-2861 and E-ISSN 1923-287X, this journal serves as a pivotal platform for sharing innovative research and advancements from 2018 through 2024. Although categorized in the fourth quartile (Q4) for 2023, its commitment to high-quality research is reflected in its ongoing efforts to foster scholarly dialogue and illuminate critical issues within its scope. Targeting primarily researchers, healthcare professionals, and students, the journal aims to disseminate crucial findings that advance our understanding of endocrine functions and metabolic processes. Given its Scopus ranking of #207 out of 244 within its category, the Journal of Endocrinology and Metabolism continues to contribute to the global discourse on these vital health topics.

Frontiers in Endocrinology

Connecting Researchers to Transform Endocrinology
Publisher: FRONTIERS MEDIA SAISSN: 1664-2392Frequency: 1 issue/year

Frontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.

Therapeutic Advances in Endocrinology and Metabolism

Pioneering research for a healthier endocrine future.
Publisher: SAGE PUBLICATIONS LTDISSN: 2042-0188Frequency: 1 issue/year

Therapeutic Advances in Endocrinology and Metabolism is a premier open-access journal published by SAGE Publications Ltd that has established itself as a leading platform for research in the field of endocrinology, diabetes, and metabolism. With a commitment to disseminating high-quality research, the journal aims to advance our understanding of therapeutic interventions and innovations in the management of endocrine disorders. Since its inception in 2010, it has garnered a strong reputation, attaining a Q1 quartile ranking in 2023 in its category and boasting a respectable Scopus rank of #53 out of 244, positioning it within the 78th percentile. As an open-access journal since 2019, Therapeutic Advances in Endocrinology and Metabolism ensures that valuable research findings are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and students alike. The journal's multifaceted objectives encompass the publication of original research, reviews, and clinical studies that contribute to the evolving dialogue surrounding endocrine health. By delivering timely and robust content, it serves as an indispensable resource for those striving to make significant contributions to this vital area of medical science.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Navigating the complexities of endocrine and metabolic health.
Publisher: SPRINGERISSN: 1389-9155Frequency: 6 issues/year

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

Archives of Endocrinology Metabolism

Exploring the intricacies of metabolism and endocrine health.
Publisher: SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIAISSN: 2359-3997Frequency: 6 issues/year

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

Journal of the ASEAN Federation of Endocrine Societies

Exploring Diabetes and Metabolism: A Gateway to Groundbreaking Research
Publisher: ASEAN FEDERATION ENDOCRINE SOCISSN: 0857-1074Frequency: 2 issues/year

Welcome to the Journal of the ASEAN Federation of Endocrine Societies, a pioneering publication dedicated to advancing knowledge and research in the fields of Endocrinology, Diabetes, and Metabolism. Established by the ASEAN Federation Endocrine Society and open access since 2011, this journal enhances the dissemination of critical findings and encourages collaboration among professionals and researchers across Southeast Asia and beyond. With an ISSN of 0857-1074 and E-ISSN of 2308-118X, the journal is indexed within Quartile 4 in the 2023 rankings of its categories, reflecting its commitment to providing a platform for scholarly work despite its emerging status. Situated in the Philippines, the journal focuses on the latest trends, treatments, and innovative research approaches in endocrinology, making it an essential resource for academics, clinicians, and students alike. We invite you to explore our content and contribute to advancing the endocrine sciences.

Journal of Diabetes

Advancing diabetes research for a healthier tomorrow.
Publisher: WILEYISSN: 1753-0393Frequency: 12 issues/year

The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.

DIABETES OBESITY & METABOLISM

Connecting researchers to enhance patient care in endocrinology.
Publisher: WILEYISSN: 1462-8902Frequency: 12 issues/year

DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.

Austrian Journal of Clinical Endocrinology and Metabolism

Elevating the standard of care for metabolic disorders.
Publisher: SPRINGER WIENISSN: 1998-7773Frequency: 4 issues/year

Austrian Journal of Clinical Endocrinology and Metabolism, published by SPRINGER WIEN, serves as a pivotal platform for the dissemination of research in the field of endocrinology, diabetes, and metabolism. With its ISSN 1998-7773 and E-ISSN 1998-7781, this journal has been contributing valuable insights to the field since its inception in 2010. Although it currently holds a Q4 ranking in the category of Endocrinology, Diabetes and Metabolism, it is committed to improving its impact factor by showcasing high-quality, peer-reviewed articles that reflect contemporary challenges and innovations in clinical endocrinology. Located in Vienna, Austria, the journal aims to provide researchers, healthcare professionals, and students with access to the latest findings and clinical practices that advance understanding and treatment of endocrine disorders. Researchers interested in submitting their work will find a supportive environment that embraces both experimental and clinical approaches. The Austrian Journal of Clinical Endocrinology and Metabolism is poised to become a valuable resource for those dedicated to improving health outcomes in metabolic disorders.

International Journal of Endocrinology

Advancing global knowledge in endocrinology and metabolism.
Publisher: HINDAWI LTDISSN: 1687-8337Frequency:

The International Journal of Endocrinology is a premier peer-reviewed journal, published by HINDAWI LTD, focusing on the rapidly evolving fields of endocrinology, diabetes, and metabolism. Since its establishment in 2009, the journal has embraced an Open Access model, ensuring that cutting-edge research is accessible to a global audience without barriers. With an impressive Scopus rank placing it within the top quartiles of related fields, it ranks #103 in Endocrinology, Diabetes and Metabolism, showcasing its significant contribution to the ongoing discourse in these areas. The journal's scope includes original research, reviews, and clinical studies that advance understanding and treatment strategies for endocrine disorders. By bridging the gap between research, clinical practice, and patient care, the International Journal of Endocrinology serves as an essential resource for researchers, practitioners, and students dedicated to the field of endocrinology. Addressed from its headquarters in the United States, this journal not only contributes to academic advancement but also fosters international collaboration in addressing key challenges in endocrinology.